For the year ended 31 March 2014 Deductible temporary differences, tax loss carry-forwards, and unused tax credits for which no deferred tax asset is recognised are  as follows: The expiration date and amount of tax loss carry-forwards for which no deferred tax asset is recognised are as follows: Financial Section Annual Report 2014 _  Astellas Pharma Inc.  127 (Millions of yen) 1 April 2012  (Transition date) 2013 2014 year 1 ¥ — ¥ 96 ¥ — year 2 84 17 87 year 3 15 183 181 year 4 160 158 87 year 5 or later 4,119 5,799 5,319 Total ¥4,378 ¥6,252 ¥5,674 (Millions of yen) 1 April 2012  (Transition date) 2013 2014 Deductible temporary differences ¥10,853 ¥24,523 ¥28,787 Tax loss carry-forwards 4,378 6,252 5,674 Unused tax credits 346 685 462 Total ¥15,577 ¥31,460 ¥34,923 (Millions of yen) As of 1 April 2013 Recognised in  profit or loss Recognised in  other comprehensive  income Other As of 31 March 2014 Deferred tax assets Available-for-sale financial assets ¥ 1,307 ¥ 290 ¥ — ¥ — ¥ 1,597 Retirement benefit liabilities 11,054 (836) (2,873) 828 8,172 Property, plant and equipment 7,170 (74) — (650) 6,446 Intangible assets 33,221 (6,348) — 311 27,184 Accrued expenses 18,389 4,791 — 1,303 24,483 Inventories 36,195 5,993 — 1,174 43,363 Tax loss carry-forwards 1,263 3,108 — 298 4,668 Other 41,335 (2,038) — 1,092 40,390 Total deferred tax assets 149,934 4,887 (2,873) 4,356 156,304 Deferred tax liabilities Available-for-sale financial assets (12,157) (15) (3,475) — (15,647) Property, plant and equipment (1,297) (146) — (126) (1,569) Intangible assets (92,883) 19,468 — (3,709) (77,124) Other (13,689) (1,906) — (841) (16,436) Total deferred tax liabilities (120,026) 17,401 (3,475) (4,676) (110,776) Net deferred tax assets (liabilities) ¥ 29,908 ¥22,288 ¥(6,347) ¥ (321) ¥ 45,527